Writing in JAMA, four former government officials warn that the Trump administration’s involvement in delaying the approval ...

The latest trading day saw Novavax (NVAX) settling at $6.36, representing a -2.15% change from its previous close.

Here’s a look at what Robert F. Kennedy Jr. has said and done since becoming the nation’s top health official on Feb. 13.

The Centers for Disease Control and Prevention's vaccine advisory committee is set to meet for the first time since Health ...

Retail investor chatter around vaccine makers Novavax, Moderna, and Pfizer rose on Wednesday, ahead of a closely watched CDC ...

The Subject Expert Committee (SEC) under the COVID-19 division of the Central Drugs Standard Control Organization (CDSCO) has ...

Novavax is a leading pharmaceutical company dedicated to creating protein-based vaccines for diseases like COVID-19 and malaria. Learn more about their innovative vaccine development process and ...

Oxford researchers have developed a single-shot malaria vaccine using programmable microcapsules that release booster doses ...

View the latest Novavax Inc. (NVAX) stock price, news, historical charts, analyst ratings and financial information from WSJ.